Evidence map›Paper›PMID 21216157›Full record

ArticleJournal of vascular and interventional radiology : JVIR2011

Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism.

Neil A Goldenberg, Brian Branchford, Michael Wang, Charles Ray, Janette D Durham, Marilyn J Manco-Johnson

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular and interventional radiology : JVIR, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. How We Manage Pediatric Deep Venous Thrombosis.Seminars in interventional radiology · 2017
    Review
  12. Pediatric Thrombolysis: A Practical Approach.Frontiers in pediatrics · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Deep vein thrombosis: thrombolysis in the pediatric population.Seminars in interventional radiology · 2012
    Article
  19. Massive Fatal Pulmonary Embolism While on Therapeutic Heparin Drip.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Neil A GoldenbergDepartment of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation and Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado, Aurora, Colorado 80045, USA. neil.goldenberg@ucdenver.edu
Brian Branchford
Michael Wang
Charles Ray
Janette D Durham
Marilyn J Manco-Johnson
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Boulder · US

Funding

Models of Care and Research in Thrombosis and ThrombophiliaU01DD000016 · DD · UNIVERSITY OF COLORADO DENVER · PI MANCO-JOHNSON, MARILYN J · 2007 to 2011
$1.1M
Clinical Investigation in Pediatric ThrombosisK23HL084055 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI GOLDENBERG, NEIL A · 2007 to 2011
$743k
NCBDD CDC HHS U01 DD000016NCBDD CDC HHS U01DD00016NHLBI NIH HHS 1K23HL084055NHLBI NIH HHS K23 HL084055
6 · The paper itself

Abstract

purposeYoung individuals with occlusive, proximal-limb deep vein thrombosis (DVT) who have acutely increased plasma levels of factor VIII and D-dimer are at high risk for postthrombotic syndrome (PTS) when treated with conventional anticoagulation alone. The present report is an evaluation of experience with adjunctive percutaneous mechanical thrombolysis (PMT) and/or percutaneous pharmacomechanical thrombolysis (PPMT) in such patients. PATIENTS AND

methodsAmong 95 children 11-21 years of age enrolled in a prospective cohort of venous thromboembolism between March 1, 2006, and November 1, 2009, 16 met eligibility criteria and underwent PMT/PPMT, typically with adjunctive catheter-directed thrombolytic infusion (CDTI) of tissue-type plasminogen activator given after the procedure.

resultsMedian age was 16 years (range, 11-19 y). Thirteen cases (81%) involved lower limbs. Underlying stenotic lesions were disclosed in 53%, with endovascular stents deployed in all cases of May-Thurner anomaly. There were no periprocedural major bleeding events and one symptomatic pulmonary embolism. Technical success rate was 94%. Early (< 30 days) locally recurrent DVT developed in 40% of cases, of which 83% were successfully treated with repeat lysis. Late recurrent DVT rate (median follow-up duration, 14 months; range, 1-42 mo) was 27%. Cumulative incidence of physically and functionally significant PTS at 1-2 years was 13%.

conclusionsThis experience provides preliminary evidence that PMT/PPMT with adjunctive CDTI can be used safely and effectively in adolescent subjects with DVT at high risk for PTS.

Indexed as

AdolescentChildColoradoCombined Modality TherapyEmbolization, TherapeuticFemaleFibrinolytic AgentsHumansLegMalePrevalenceRisk AssessmentRisk FactorsTissue Plasminogen ActivatorTreatment OutcomeVenous ThrombosisFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID21216157
PMCPMC3058325
OpenAlexW2091699051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.